Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic: Melanoma.
    Difference
    0.2%
    Check dated 2025-10-13T12:27:22.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Update: Version bumped to v3.2.0 and a new government funding operating-status notice added; previous v3.1.0 revision removed.
    Difference
    3%
    Check dated 2025-10-06T08:25:09.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Adds a new MedlinePlus Genetics topic on Melanoma and updates the page revision from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-29T05:09:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic: Melanoma.
    Difference
    0.2%
    Check dated 2025-09-22T02:55:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top element was removed, which is a minor UI change with no impact on core information.
    Difference
    0.2%
    Check dated 2025-09-14T23:14:03.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page has been updated to include information on Melanoma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.4%
    Check dated 2025-09-07T19:52:28.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.